Results 211 to 220 of about 33,896 (240)

Contact-aware multi-skill learning framework with hybrid force-motion control for stability and force regulation in robotic physiotherapy. [PDF]

Front Robot AI
Zhai X, Feng Q, Zheng H, Luo Y, Hao H, Yan A, Wu H.   +6 more
europepmc   +1 more source

Oxidative functionalization of carbon nanotubes for enhanced adsorptive removal of phthalate esters in environmental systems. [PDF]

Nanoscale Adv
G K, T SK, Sasikumar R, Rajarathinam R, Haorongbam S, Senthilkumar, Jaiswal AK.   +6 more
europepmc   +1 more source

Autoimmunity: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities

MedComm, Volume 7, Issue 9, September 2026.
Major types of immunometabolism, epigenetics, posttranscriptional regulation, and functional reprogramming involved in autoimmune diseases. The roles of immunometabolism, epigenetics, posttranscriptional regulation, and functional reprogramming in autoimmune diseases have been a major research focus in recent years.
Jialong Kuang, Yin Zhu, Fang Xu, Yongjing Liu, Yuan Li, Ling Yuan, Liqin Wei, Bo Huang, Yan Chen, Pei Huang, Zuochen Du   +10 more
wiley   +1 more source

Sequential Release of mRNA Complex and T Cells by a Double-Layered Implantable Scaffold for Combination Therapy of Head and Neck Squamous Cell Carcinoma. [PDF]

Int J Nanomedicine
Ma P, Gao Y, Wu S, Chen X, Fu X, Cai Y, Men K, Li L, Li C.   +8 more
europepmc   +1 more source

Aniline Degradation via 2-Aminophenol: Genetic Basis, Broadened Players and Interspecies Cooperation. [PDF]

Environ Microbiol
Xu S, Liu P, Zheng L, Liu N, Zhao H, Jiang Y.   +5 more
europepmc   +1 more source

Multiple novel membrane proteins involve phthalate ester degradation in <i>Rhodococcus</i> sp. AH-ZY2. [PDF]

Appl Environ Microbiol
Hou Z, Pan H, Wang S, Li Y, Yu Y, Qiao P, Wang H, Zhong W.   +7 more
europepmc   +1 more source

Oxidative stability as a guiding principle for durable ionomer cations in pure-water electrolysis. [PDF]

Nat Commun
Jin Y, Wu B, Li W, Wang C, Fan L, Wen L, Li J, Wang J, Lei J, Fan J, Li H.   +10 more
europepmc   +1 more source

The Utilization of Lipid-Lowering Drugs and Participation in the German Disease Management Program for Coronary Artery Disease in Patients With Atherosclerotic Disease: An Analysis of Claims Data. [PDF]

Dtsch Arztebl Int
Kogel A, Müller LM, Krampe J, Laufs U, Katzmann JL.   +4 more
europepmc   +1 more source

Real-world effectiveness of burosumab across age groups: X-linked hypophosphatemia (XLH) Disease Monitoring Program.

J Clin Endocrinol Metab
Ward LM, Carpenter TO, Cassinelli H, Florenzano P, Imel EA, Khan AA, Johnson B, Yang E, Vincent M, Heerssen HM, Li Z, Simmons JH.   +11 more
europepmc   +1 more source